These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38960793)

  • 1. Role of neuromuscular blocking agents in the development of polyneuropathy and myopathy in critically ill patients.
    Armestar F; Vitoria Rubio S; Ojanguren Sabán I; Coll-Cantí J; Perez Molto H
    Med Clin (Barc); 2024 Oct; 163(7):323-326. PubMed ID: 38960793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular Blocking Agents and Neuromuscular Dysfunction Acquired in Critical Illness: A Systematic Review and Meta-Analysis.
    Price DR; Mikkelsen ME; Umscheid CA; Armstrong EJ
    Crit Care Med; 2016 Nov; 44(11):2070-2078. PubMed ID: 27513545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge.
    Koch S; Spuler S; Deja M; Bierbrauer J; Dimroth A; Behse F; Spies CD; Wernecke KD; Weber-Carstens S
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):287-93. PubMed ID: 20802220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intensive care unit-acquired weakness: development of polyneuropathy and myopathy in critically ill patients].
    Takei T
    Brain Nerve; 2014 Feb; 66(2):161-70. PubMed ID: 24523314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.
    Apostolakis E; Papakonstantinou NA; Baikoussis NG; Papadopoulos G
    J Anesth; 2015 Feb; 29(1):112-21. PubMed ID: 24981564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical illness associated neuromuscular disorders -- keep them in mind.
    Nemes R; Molnár L; Fülep Z; Fekete K; Berhés M; Fülesdi B
    Ideggyogy Sz; 2014 Nov; 67(11-12):364-75. PubMed ID: 25720238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of neuromuscular electrical stimulation in critically ill patients.
    Segers J; Hermans G; Bruyninckx F; Meyfroidt G; Langer D; Gosselink R
    J Crit Care; 2014 Dec; 29(6):1082-8. PubMed ID: 25108833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICU-Acquired Weakness Is Associated With Differences in Clinical Outcomes in Critically Ill Children.
    Field-Ridley A; Dharmar M; Steinhorn D; McDonald C; Marcin JP
    Pediatr Crit Care Med; 2016 Jan; 17(1):53-7. PubMed ID: 26492063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: A historical review.
    Wilcox SR
    J Crit Care; 2017 Feb; 37():149-155. PubMed ID: 27736708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].
    Judemann K; Lunz D; Zausig YA; Graf BM; Zink W
    Anaesthesist; 2011 Oct; 60(10):887-901. PubMed ID: 22006117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology of neuromuscular impairments in the critically ill patient].
    García de Lorenzo A; Vilas E; Rodríguez Montes JA
    Nutr Hosp; 2006 May; 21 Suppl 3():96-103. PubMed ID: 16768036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute weakness syndromes in critically ill patients--a reappraisal.
    Nates JL; Cooper DJ; Day B; Tuxen DV
    Anaesth Intensive Care; 1997 Oct; 25(5):502-13. PubMed ID: 9352763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive care unit-acquired weakness: unanswered questions and targets for future research.
    Piva S; Fagoni N; Latronico N
    F1000Res; 2019; 8():. PubMed ID: 31069055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical consequences of neuromuscular impairments in critically ill patients].
    Mesejo A; Pérez-Sancho E; Moreno E
    Nutr Hosp; 2006 May; 21 Suppl 3():104-13. PubMed ID: 16768037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for preventing critical illness polyneuropathy and critical illness myopathy.
    Hermans G; De Jonghe B; Bruyninckx F; Van den Berghe G
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD006832. PubMed ID: 24477672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure.
    Hund EF; Fogel W; Krieger D; DeGeorgia M; Hacke W
    Crit Care Med; 1996 Aug; 24(8):1328-33. PubMed ID: 8706487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICU-acquired weakness.
    Schweickert WD; Hall J
    Chest; 2007 May; 131(5):1541-9. PubMed ID: 17494803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular weakness in critically ill.
    Khilnani GC; Bansal R
    J Assoc Physicians India; 2004 Feb; 52():131-6. PubMed ID: 15656048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit.
    Hermans G; Wilmer A; Meersseman W; Milants I; Wouters PJ; Bobbaers H; Bruyninckx F; Van den Berghe G
    Am J Respir Crit Care Med; 2007 Mar; 175(5):480-9. PubMed ID: 17138955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels.
    Larsson L; Li X; Edström L; Eriksson LI; Zackrisson H; Argentini C; Schiaffino S
    Crit Care Med; 2000 Jan; 28(1):34-45. PubMed ID: 10667496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.